Northwest Kinetics
Northwest Kinetics runs clinical trials, primarily in Phase I facility, with a focus on high end clinical pharmacology studies.
Launch date
Market cap
-
Enterprise valuation
€27m (Public information from Oct 2006)
Tacoma Washington (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$29.5m Valuation: $29.5m | Acquisition | ||
| Total Funding | - | ||